The art of cobbling a running pump--will human embryonic stem cells mend broken hearts?
The heart is one of the least regenerative organs in the body, and highly vulnerable to the increasing incidence of cardiovascular diseases in an aging world population. Cell-based approaches aimed at cardiac repair have recently caused great public excitement. But clinical trials of patients' own skeletal myoblasts or bone marrow cells for transplantation have been disappointing. Human embryonic stem cells (hESCs) form bona fide cardiomyocytes in vitro which are readily generated in mass culture and are being tested in animal models of heart damage. The early results, while encouraging, underscore that much remains to be done. This review focuses on the many challenges that remain before hESCs-mediated repair of the human heart becomes a reality.
Zweigerdt
Robert
R
Institute of Medical Biology, 11 Biopolis Way, # 5-6 Helios, 138667 Singapore, Singapore. robert.zweigerdt@imb.a-star.edu.sg
D017690:Cell Transplantation; D053595:Embryonic Stem Cells / Q000166:cytology / Q000502:physiology*; D006331:Heart Diseases / Q000628:therapy*; D006801:Humans; D032383:Myocytes, Cardiac / Q000166:cytology* / Q000637:transplantation; D012038:Regeneration